Loading...
Market
Edwards Lifesciences' stock price movement one month after the sale announcement?
4
Resolution / Starting Odds
Increase by more than 10% • 33%
Increase by less than 10% • 33%
Decrease • 33%
Stock price data from financial markets
Story
Edwards Lifesciences to Sell Critical Care Unit to Becton Dickinson for $4.2 Billion in Cash
Jun 3, 2024, 12:26 PM
Edwards Lifesciences has agreed to sell its critical care products unit to Becton Dickinson for $4.2 billion in an all-cash transaction. The move is aimed at allowing Edwards Lifesciences to focus more on its heart devices business. Becton Dickinson, also known as BD, plans to expand its portfolio of smart medical monitoring and patient monitoring products through this acquisition. The deal was announced on Monday, June 3, 2024, and has positively impacted the stock prices of both companies, with BDX up 2.2% and EW up 3.6% in pre-market trading.
View original story
Similar markets
Increase more than 10% • 25%
Increase 5-10% • 25%
Increase less than 5% • 25%
Decrease • 25%
Increases by more than 10% • 33%
Changes between 0% and 10% • 33%
Decreases • 34%
Yes • 50%
No • 50%
Increase more than 10% • 25%
Increase 5% to 10% • 25%
Decrease or change less than 5% • 25%
Decrease more than 5% • 25%
Increase 10% or more • 25%
Increase less than 10% • 25%
Decrease less than 10% • 25%
Decrease 10% or more • 25%
Increase by over 10% • 25%
Increase by 5% to 10% • 25%
Increase by less than 5% • 25%
Decrease • 25%
Increase by more than 5% • 25%
Increase by less than 5% • 25%
Decrease by less than 5% • 25%
Decrease by more than 5% • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Up by 5% or more • 33%
Down by 5% or more • 33%
Unchanged or minor change (<5%) • 33%
Yes • 50%
No • 50%
Increase by more than 5% • 33%
Increase by less than 5% • 33%
No significant change • 33%